Corteva, Inc. (NYSE:CTVA) Shares Acquired by Aptus Capital Advisors LLC

Aptus Capital Advisors LLC boosted its holdings in Corteva, Inc. (NYSE:CTVA) by 7.2% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,503 shares of the company’s stock after purchasing an additional 303 shares during the period. Aptus Capital Advisors LLC’s holdings in Corteva were worth $265,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of CTVA. Acadian Asset Management LLC acquired a new stake in shares of Corteva in the 1st quarter valued at about $25,000. Capital Advisors Ltd. LLC raised its stake in Corteva by 44.4% during the third quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock valued at $33,000 after buying an additional 174 shares in the last quarter. Cultivar Capital Inc. acquired a new position in shares of Corteva in the 2nd quarter worth approximately $34,000. Redwood Wealth Management Group LLC bought a new stake in shares of Corteva in the 2nd quarter valued at approximately $43,000. Finally, Triad Wealth Partners LLC acquired a new stake in shares of Corteva during the 2nd quarter valued at approximately $45,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on CTVA shares. Argus lowered shares of Corteva from a “buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Bank of America upgraded shares of Corteva from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $59.00 to $67.00 in a research note on Wednesday, October 16th. KeyCorp decreased their target price on Corteva from $66.00 to $62.00 and set an “overweight” rating for the company in a research note on Friday, August 2nd. Royal Bank of Canada dropped their price target on Corteva from $69.00 to $68.00 and set an “outperform” rating on the stock in a research report on Monday, November 11th. Finally, UBS Group boosted their price objective on Corteva from $67.00 to $71.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and an average target price of $63.68.

Corteva Price Performance

NYSE CTVA opened at $55.21 on Friday. Corteva, Inc. has a 12 month low of $43.89 and a 12 month high of $63.75. The firm has a market capitalization of $37.95 billion, a PE ratio of 55.77, a P/E/G ratio of 1.85 and a beta of 0.77. The company’s 50 day simple moving average is $58.34 and its 200 day simple moving average is $55.66. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.50 and a quick ratio of 0.96.

Corteva Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.23%. The ex-dividend date is Monday, December 2nd. Corteva’s dividend payout ratio is presently 68.69%.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.